In the current study, we evaluated PD-L1 expression in a large cohort of TETs with two different clones (SP142, SP263), both in tumor and immune cells, and investigated its correlation with tumor subtypes, disease stage, relapse, and survival. The gene discussed is CD274; the disease is neoplasm.